References
- 1. WHO. Cardiovascular diseases [Internet]. [cited 2022 Dec 20]. Available from: https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1
- 2. Sacco RL, Roth GA, Reddy KS, Arnett DK, Bonita R, Gaziano TA, et al. The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke. Circulation. 2016 Jun 7;133(23):e674-90. DOI: 10.1161/CIR.000000000000039527162236
- 3. Fan H, Li X, Zheng L, Chen X, lan Q, Wu H, et al. Abdominal obesity is strongly associated with Cardiovascular Disease and its Risk Factors in Elderly and very Elderly Community-dwelling Chinese. Sci Rep. 2016 Aug 17;6(1):21521. DOI: 10.1038/srep21521475633126882876
- 4. Wilding JPH, Jacob S. Cardiovascular outcome trials in obesity: A review. Obesity Reviews. 2021 Jan 7;22(1). DOI: 10.1111/obr.1311232893459
- 5. Fang H, Berg E, Cheng X, Shen W. How to best assess abdominal obesity. Curr Opin Clin Nutr Metab Care. 2018 Sep 1;21(5):360-5. DOI: 10.1097/MCO.0000000000000485629945029916924
- 6. Ross R, Neeland IJ, Yamashita S, Shai I, Seidell J, Magni P, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020 Mar 4;16(3):177-89. DOI: 10.1038/s41574-019-0310-7702797032020062
- 7. Neeland IJ, Ross R, Després J-P, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol. 2019 Sep 1;7(9):715-25. DOI: 10.1016/S2213-8587(19)30084-131301983
- 8. Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Circ Res. 2021 Apr 2;128(7):951-68. DOI: 10.1161/CIRCRESAHA.121.318093802627233793327
- 9. Després JP. Abdominal obesity and cardiovascular disease: is inflammation the missing link? Can J Cardiol. 2012 Nov;28(6):642-52. DOI: 10.1016/j.cjca.2012.06.00422889821
- 10. Linder N, Michel S, Eggebrecht T, Schaudinn A, Blüher M, Dietrich A, et al. Estimation of abdominal subcutaneous fat volume of obese adults from single-slice MRI data - Regression coefficients and agreement. Eur J Radiol. 2020 Sep 1;130:109184. DOI: 10.1016/j.ejrad.2020.10918432712498
- 11. Xu Z, Liu Y, Yan C, Yang R, Xu L, Guo Z, et al. Measurement of visceral fat and abdominal obesity by single-frequency bioelectrical impedance and CT: a cross-sectional study. BMJ Open. 2021 Oct 11;11(10):e048221. DOI: 10.1136/bmjopen-2020-048221850685434635516
- 12. Chen S, Ma D, Su D, Li Y, Yu X, Jiang Y, et al. The Optimal Axial Anatomical Site for a Single-Slice Area to Quantify the Total Volume of Visceral Adipose Tissue in Quantitative CT. Front Endocrinol (Lausanne). 2022 Jun 23;13. DOI: 10.3389/fendo.2022.870552925994335813654
- 13. Pop RM, Pop M, Dogaru G, Bacarea VC. A web-based nutritional assessment tool. Studies in Informatics and Control. 2013;22(2):307-14. DOI: 10.24846/v22i3y201307
- 14. Fernández-Friera L, Fuster V, López-Melgar B, Oliva B, García-Ruiz JM, Mendiguren J, et al. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017 Dec 19;70(24):2979-91. DOI: 10.1016/j.jacc.2017.10.02429241485
- 15. Poznyak A v, Litvinova L, Poggio P, Sukhorukov VN, Orekhov AN. Effect of Glucose Levels on Cardiovascular Risk. Cells. 2022 Sep 28;11(19):3034. DOI: 10.3390/cells11193034956287636230996
- 16. Park C, Guallar E, Linton JA, Lee D-C, Jang Y, Son DK, et al. Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases. Diabetes Care. 2013 Jul 1;36(7):1988-93. DOI: 10.2337/dc12-1577368730423404299
- 17. Farnier M, Zeller M, Masson D, Cottin Y. Triglycerides and risk of atherosclerotic cardiovascular disease: An update. Arch Cardiovasc Dis. 2021 Feb 1;114(2):132-9. DOI: 10.1016/j.acvd.2020.11.00633546998
- 18. Ye X, Kong W, Zafar MI, Chen L-L. Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies. Cardiovasc Diabetol. 2019 Apr 15;18(1):48. DOI: 10.1186/s12933-019-0851-z646665830987625
- 19. Conget I, Giménez M. Glucose Control and Cardiovascular Disease. Diabetes Care. 2009 Nov 1;32(suppl_2):S334-6. DOI: 10.2337/dc09-S334281144919875576
- 20. Harchaoui K, Visser M, Kastelein J, Stroes E, Dallinga-Thie G. Triglycerides and Cardiovascular Risk. Curr Cardiol Rev. 2009 Aug 1;5(3):216-22. DOI: 10.2174/157340309788970315282214420676280
- 21. McBride P. Triglycerides and risk for coronary artery disease. Curr Atheroscler Rep. 2008 Oct 16;10(5):386-90. DOI: 10.1007/s11883-008-0060-918706279
- 22. Park G-M, Cho Y-R, Won K-B, Yang YJ, Park S, Ann SH, et al. Triglyceride glucose index is a useful marker for predicting subclinical coronary artery disease in the absence of traditional risk factors. Lipids Health Dis. 2020 Jan 14;19(1):7. DOI: 10.1186/s12944-020-1187-0696124031937313
- 23. Tao L-C, Xu J, Wang T, Hua F, Li J-J. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022 Dec 6;21(1):68. DOI: 10.1186/s12933-022-01511-x907801535524263
- 24. Pop M, Pop R. ECR 2014, Part B. Insights Imaging. 2014 Mar 27;5(S1):135-368. DOI: 10.1007/s13244-014-0317-5394818124573559
- 25. SJÖSTRÖM L, KVIST H. Regional body fat measurements with CT-scan and evaluation of anthropometric predictions. Acta Med Scand Suppl. 1988;723(723 S):169-77. DOI: 10.1111/j.0954-6820.1987.tb05941.x3164964
- 26. Rasband WS. ImageJ [Internet]. U. S. National Institutes of Health, Bethesda, Maryland, USA; Available from: https://imagej.nih.gov/ij/
- 27. Ciudin A, Salvador R, Budoy A, Ciudin A, Spinu C, Diaconu MG, et al. Measurement of waist circumference for retrospective studies - prospective validation of use of CT images to assess abdominal circumference. Endocrinol Nutr. 2014 Mar;61(3):147-52. DOI: 10.1016/j.endonu.2013.10.00424342428
- 28. Villarino MB. Ramanujan’s Perimeter of an Ellipse. 2005;
- 29. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008 Dec 1;6(4):299-304. DOI: 10.1089/met.2008.003419067533
- 30. IBM. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp.; 2017.
- 31. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007 Jul;116(1):39-48. DOI: 10.1161/CIRCULATIONAHA.106.67535517576866
- 32. Kvist H, Chowdhury B, Sjostrom L, Tylen U, Cederblad A. Adipose tissue volume determination in males by computed tomography and 40K. Int J Obes. 1988;12(3):249-66.
- 33. Enzi G, Gasparo M, Raimondo Biondetti P, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. American Journal of Clinical Nutrition. 1986;44(6):739-46. DOI: 10.1093/ajcn/44.6.7393788827
- 34. Yoshizumi T, Nakamura T, Yamane M, Islam AH, Menju M, Yamasaki K, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999 Apr 1;211(1):283-6. DOI: 10.1148/radiology.211.1.r99ap1528310189485
- 35. Després J-P. Body Fat Distribution and Risk of Cardiovascular Disease. Circulation. 2012 Sep 4;126(10):1301-13. DOI: 10.1161/CIRCULATIONAHA.111.06726422949540
- 36. Hiuge-Shimizu A, Kishida K, Funahashi T, Ishizaka Y, Oka R, Okada M, et al. Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study). Ann Med. 2012 Feb 22;44(1):82-92. DOI: 10.3109/07853890.2010.52613820964583
- 37. Anderson PJ, Chan JCN, Chan YL, Tomlinson B, Young RP, Lee ZSK, et al. Visceral Fat and Cardiovascular Risk Factors in Chinese NIDDM Patients. Diabetes Care. 1997 Dec 1;20(12):1854-8. DOI: 10.2337/diacare.20.12.18549405906
- 38. Saito K, Shimamoto T, Takahashi Y, Okushin K, Takahashi M, Masuda Y, et al. Gender-specific factors contributing to visceral obesity including the sleep-obesity relationship: a large-scale cross-sectional study from East Asia. Sci Rep. 2022 Nov 24;12(1):20318. DOI: 10.1038/s41598-022-24863-6970070136434061
- 39. Sukkriang N, Chanprasertpinyo W, Wattanapisit A, Punsawad C, Thamrongrat N, Sangpoom S. Correlation of body visceral fat rating with serum lipid profile and fasting blood sugar in obese adults using a noninvasive machine. Heliyon. 2021 Feb 1;7(2):e06264. DOI: 10.1016/j.heliyon.2021.e06264789343333644479
- 40. Tchernof A, Després J-P. Pathophysiology of human visceral obesity: an update. Physiol Rev. 2013 Jan 1;93(1):359-404. DOI: 10.1152/physrev.00033.201123303913
- 41. Leenen R, van der Kooy K, Seidell JC, Deurenberg P. Visceral fat accumulation measured by magnetic resonance imaging in relation to serum lipids in obese men and women. Atherosclerosis. 1992 Jun 1;94(2-3):171-81. DOI: 10.1016/0021-9150(92)90242-91632871
- 42. Seidell JC, Bakker CJ, van der Kooy K. Imaging techniques for measuring adipose-tissue distribution--a comparison between computed tomography and 1.5-T magnetic resonance. Am J Clin Nutr. 1990 Jun 1;51(6):953-7. DOI: 10.1093/ajcn/51.6.9532349931
- 43. Nemoto M, Yeernuer T, Masutani Y, Nomura Y, Hanaoka S, Miki S, et al. Development of Automatic Visceral Fat Volume Calculation Software for CT Volume Data. J Obes. 2014;2014:1-7. DOI: 10.1155/2014/495084398148724782922
- 44. Kim SS, Kim J-H, Jeong WK, Lee J, Kim YK, Choi D, et al. Semiautomatic software for measurement of abdominal muscle and adipose areas using computed tomography. Medicine. 2019 May 1;98(22):e15867. DOI: 10.1097/MD.0000000000015867670881231145342
- 45. Yi W, Kim K, Im M, Ryang S, Kim EH, Kim M, et al. Association between visceral adipose tissue volume, measured using computed tomography, and cardio-metabolic risk factors. Sci Rep. 2022 Jan 10;12(1):387. DOI: 10.1038/s41598-021-04402-5874843235013484
- 46. Wendler G, Nassif PAN, Malafaia O, Wendler E, Wendler IBT, Cirpiani LM. HELICAL COMPUTERIZED TOMOGRAPHY CAN MEASURE SUBCUTANEOUS, VISCERAL AND TOTAL FAT AREAS? Arq Bras Cir Dig. 2022;34(3):e1591. DOI: 10.1590/0102-672020210003e1591873526535019117